These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31822328)
21. A man with tropical travel history, fever, and pulmonary infiltrates. Wongba W; Ansari MJ; Okoli O; Garapati S; Iroegbu N; Spear JB Compr Ther; 2007; 33(1):21-4. PubMed ID: 17984489 [TBL] [Abstract][Full Text] [Related]
22. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD; J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549 [TBL] [Abstract][Full Text] [Related]
23. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Boggild AK; Parise ME; Lewis LS; Kain KC Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027 [TBL] [Abstract][Full Text] [Related]
24. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand. Khositnithikul R; Tan-Ariya P; Mungthin M Malar J; 2008 Jan; 7():23. PubMed ID: 18226262 [TBL] [Abstract][Full Text] [Related]
25. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris]. Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692 [TBL] [Abstract][Full Text] [Related]
32. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361 [TBL] [Abstract][Full Text] [Related]
33. Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate. Rodriguez-Valero N; Castro P; Martinez G; Marco Hernandez J; Fernandez S; Gascon J; Nicolas JM J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29394389 [TBL] [Abstract][Full Text] [Related]
34. Two cases of Plasmodium falciparum malaria in the Netherlands without recent travel to a malaria-endemic country. Arends JE; Oosterheert JJ; Kraaij-Dirkzwager MM; Kaan JA; Fanoy EB; Haas PJ; Scholte EJ; Kortbeek LM; Sankatsing SU Am J Trop Med Hyg; 2013 Sep; 89(3):527-30. PubMed ID: 23857021 [TBL] [Abstract][Full Text] [Related]
35. Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria. Polhemus ME; Remich S; Ogutu B; Waitumbi J; Lievens M; Ballou WR; Heppner DG Antimicrob Agents Chemother; 2008 Apr; 52(4):1493-5. PubMed ID: 18268090 [TBL] [Abstract][Full Text] [Related]
36. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
37. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border. Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921 [TBL] [Abstract][Full Text] [Related]
38. [Value of malarone in therapy of malaria tropica]. Ziegler T; Schau A; Winkler C Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244 [TBL] [Abstract][Full Text] [Related]